Apr 20, 2018
1:200
For every 200 shares held, investors received 1. The price per share adjusted from $0.05 to $0.00.
The split itself did not change the total investment value.
Canntab Therapeutics Limited (CTABF) trades on the Other OTC in the Drug Manufacturers - Specialty & Generic industry.
Canntab Therapeutics Limited company overviewThe latest split shown was on April 20, 2018. It was a 1-for-200 reverse split, so shareholders received 1 share for every 200 they held.
This history records one reverse split, on April 20, 2018.
Already premium?